| Year |
Citation |
Score |
| 2024 |
Finnerty MT, Khan A, You K, Wang R, Gu G, Layman D, Chen Q, Elhadad N, Joshi S, Appelbaum PS, Lencz T, Markx S, Kushner SA, Rzhetsky A. Prevalence and incidence measures for schizophrenia among commercial health insurance and medicaid enrollees. Schizophrenia (Heidelberg, Germany). 10: 68. PMID 39174558 DOI: 10.1038/s41537-024-00490-0 |
0.413 |
|
| 2023 |
Rao SB, Brundu F, Chen Y, Sun Y, Zhu H, Shprintzen RJ, Tomer R, Rabadan R, Leong KW, Markx S, Xu B, Gogos JA. Aberrant pace of cortical neuron development in brain organoids from patients with 22q11.2 deletion syndrome and schizophrenia. Biorxiv : the Preprint Server For Biology. PMID 37873382 DOI: 10.1101/2023.10.04.557612 |
0.767 |
|
| 2022 |
Rabadan MA, De La Cruz ED, Rao SB, Chen Y, Gong C, Crabtree G, Xu B, Markx S, Gogos JA, Yuste R, Tomer R. An in vitro model of neuronal ensembles. Nature Communications. 13: 3340. PMID 35680927 DOI: 10.1038/s41467-022-31073-1 |
0.722 |
|
| 2021 |
Zoghbi AW, Dhindsa RS, Goldberg TE, Mehralizade A, Motelow JE, Wang X, Alkelai A, Harms MB, Lieberman JA, Markx S, Goldstein DB. High-impact rare genetic variants in severe schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34903660 DOI: 10.1073/pnas.2112560118 |
0.429 |
|
| 2021 |
Li Y, Xia Y, Zhu H, Luu E, Huang G, Sun Y, Sun K, Markx S, Leong KW, Xu B, Fu BM. Investigation of Neurodevelopmental Deficits of 22 q11.2 Deletion Syndrome with a Patient-iPSC-Derived Blood-Brain Barrier Model. Cells. 10. PMID 34685556 DOI: 10.3390/cells10102576 |
0.491 |
|
| 2017 |
Bouwkamp CG, Kievit AJA, Markx S, Friedman JI, van Zutven L, van Minkelen R, Vrijenhoek T, Xu B, Sterrenburg-van de Nieuwegiessen I, Veltman JA, Bonifati V, Kushner SA. Copy Number Variation in Syndromic Forms of Psychiatric Illness: The Emerging Value of Clinical Genetic Testing in Psychiatry. The American Journal of Psychiatry. 174: 1036-1050. PMID 29088930 DOI: 10.1176/Appi.Ajp.2017.16080946 |
0.337 |
|
| 2015 |
Bergink V, Armangue T, Titulaer MJ, Markx S, Dalmau J, Kushner SA. Autoimmune Encephalitis in Postpartum Psychosis. The American Journal of Psychiatry. 172: 901-8. PMID 26183699 DOI: 10.1176/Appi.Ajp.2015.14101332 |
0.346 |
|
| 2014 |
Strauss KA, Markx S, Georgi B, Paul SM, Jinks RN, Hoshi T, McDonald A, First MB, Liu W, Benkert AR, Heaps AD, Tian Y, Chakravarti A, Bucan M, Puffenberger EG. A population-based study of KCNH7 p.Arg394His and bipolar spectrum disorder. Human Molecular Genetics. 23: 6395-406. PMID 24986916 DOI: 10.1093/Hmg/Ddu335 |
0.352 |
|
| 2014 |
Karayannis T, Au E, Patel JC, Kruglikov I, Markx S, Delorme R, Héron D, Salomon D, Glessner J, Restituito S, Gordon A, Rodriguez-Murillo L, Roy NC, Gogos JA, Rudy B, et al. Cntnap4 differentially contributes to GABAergic and dopaminergic synaptic transmission. Nature. 511: 236-40. PMID 24870235 DOI: 10.1038/Nature13248 |
0.65 |
|
| 2014 |
Ellegood J, Markx S, Lerch JP, Steadman PE, Genç C, Provenzano F, Kushner SA, Henkelman RM, Karayiorgou M, Gogos JA. A highly specific pattern of volumetric brain changes due to 22q11.2 deletions in both mice and humans. Molecular Psychiatry. 19: 6. PMID 24362540 DOI: 10.1038/Mp.2013.179 |
0.612 |
|
| 2014 |
Ellegood J, Markx S, Lerch JP, Steadman PE, Genç C, Provenzano F, Kushner SA, Henkelman RM, Karayiorgou M, Gogos JA. Neuroanatomical phenotypes in a mouse model of the 22q11.2 microdeletion. Molecular Psychiatry. 19: 99-107. PMID 23999526 DOI: 10.1038/Mp.2013.112 |
0.719 |
|
| 2013 |
Fénelon K, Xu B, Lai CS, Mukai J, Markx S, Stark KL, Hsu PK, Gan WB, Fischbach GD, MacDermott AB, Karayiorgou M, Gogos JA. The pattern of cortical dysfunction in a mouse model of a schizophrenia-related microdeletion. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 14825-39. PMID 24027283 DOI: 10.1523/Jneurosci.1611-13.2013 |
0.712 |
|
| 2013 |
Ryan SA, Costello DJ, Cassidy EM, Brown G, Harrington HJ, Markx S. Anti-NMDA receptor encephalitis: a cause of acute psychosis and catatonia. Journal of Psychiatric Practice. 19: 157-61. PMID 23507817 DOI: 10.1097/01.Pra.0000428562.86705.Cd |
0.335 |
|
| 2011 |
Lancaster E, Huijbers MG, Bar V, Boronat A, Wong A, Martinez-Hernandez E, Wilson C, Jacobs D, Lai M, Walker RW, Graus F, Bataller L, Illa I, Markx S, Strauss KA, et al. Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Annals of Neurology. 69: 303-11. PMID 21387375 DOI: 10.1002/Ana.22297 |
0.309 |
|
| 2011 |
Drew LJ, Crabtree GW, Markx S, Stark KL, Chaverneff F, Xu B, Mukai J, Fenelon K, Hsu PK, Gogos JA, Karayiorgou M. The 22q11.2 microdeletion: fifteen years of insights into the genetic and neural complexity of psychiatric disorders. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 29: 259-81. PMID 20920576 DOI: 10.1016/J.Ijdevneu.2010.09.007 |
0.585 |
|
| 2010 |
Karam CS, Ballon JS, Bivens NM, Freyberg Z, Girgis RR, Lizardi-Ortiz JE, Markx S, Lieberman JA, Javitch JA. Signaling pathways in schizophrenia: emerging targets and therapeutic strategies. Trends in Pharmacological Sciences. 31: 381-90. PMID 20579747 DOI: 10.1016/J.Tips.2010.05.004 |
0.471 |
|
| 2010 |
Arguello PA, Markx S, Gogos JA, Karayiorgou M. Development of animal models for schizophrenia. Disease Models & Mechanisms. 3: 22-6. PMID 20075378 DOI: 10.1242/Dmm.003996 |
0.775 |
|
| 2008 |
Friedman JI, Vrijenhoek T, Markx S, Janssen IM, van der Vliet WA, Faas BH, Knoers NV, Cahn W, Kahn RS, Edelmann L, Davis KL, Silverman JM, Brunner HG, van Kessel AG, Wijmenga C, et al. CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. Molecular Psychiatry. 13: 261-6. PMID 17646849 DOI: 10.1038/Sj.Mp.4002049 |
0.456 |
|
| Show low-probability matches. |